Related Experiment Video
Updated: May 13, 2026
Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis
Published on: December 20, 2024
Treatment of allergic rhinitis: does it make a difference in sleep and quality of life?
Mehmet Özkaya1, Zehra Bayazıt2, Burcu Özge Erdoğan2
1Division of Pediatric Allergy, Department of Pediatrics, Faculty of Medicine, Erciyes University, Kayseri, Türkiye; dr.mehmetozk@gmail.com.
Objective:
Allergic rhinitis (AR) and allergic conjunctivitis (AC) are common atopic conditions of childhood that significantly impair sleep quality and health-related quality of life (HRQoL). Although effective treatment strategies exist, their broader impact on sleep and daily functioning has remained underexplored. This study aimed to evaluate the effect of AR and/or AC treatment on sleep quality and HRQoL in children using validated, parent-reported instruments.
Methods:
In this prospective observational cohort study, 98 children aged 6-13 years with AR and/or AC were treated according to standard guidelines. Sleep quality and HRQoL were assessed pre- and post-treatment using the Children's Sleep Habits Questionnaire (CSHQ) and the Pediatric Rhinoconjunctivitis Quality of Life Questionnaire (PRQLQ), respectively. Changes in scores were analyzed using the Wilcoxon Signed-Rank test.
Results:
Post-treatment evaluations demonstrated a significant reduction in total CSHQ scores (median: 56-43, P < 0.001), indicating improved sleep quality. Similarly, total PRQLQ scores decreased significantly (median: 3.47-2.28, P < 0.001), reflecting enhanced QoL. Improvements were observed in most subdomains, including nose and eye symptoms, activity limitations, and other symptoms.
Conclusions:
A 4-week standard treatment regimen for AR and/or AC led to significant improvements in sleep quality and HRQoL in children. These findings highlight the importance of early and appropriate management of allergic conditions to enhance both physical and functional well-being in pediatric patients.
Related Concept Videos
01:16Drugs Used in Upper Respiratory Disorders: Overview
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
01:30Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
01:19Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
01:15Upper Respiratory Drugs: First and Second-Generation Antihistamines
Histamine binds to specific receptor sites, known as H1 receptors, on tissue cells, triggering inflammation and swelling. Antihistamines combat these effects by competing with histamine for these receptor sites. By...
01:24Asthma-III: Symptoms and Complications
Classification of Asthma